Journal of Immunology Research / 2013 / Article / Fig 3

Clinical Study

Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy

Figure 3

Kaplan-Meier estimates of progression-free survival (PFS) and overall survival (OS). Left figure: PFS. Blue line: CIK cell treatment group. Red line: control group. Log-rank: . Right figure: OS. Blue line: CIK cell treatment group. Red line: control group. Log-rank: ; all patients were alive during the course of followup, and there were no statistically significant differences between two groups in OS.
195691.fig.003

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.